Delivery Order SPE2DP24D0004-SPE2DP24F3312
- Not listed
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency Troop Support Medical to Seqirus USA Inc., a global biotechnology company that specializes in influenza vaccines. The $179,917.20 contract is for the delivery of influenza virus vaccines to support immunization programs for military personnel. Seqirus USA Inc., through its Seqirus USA, Inc. Division, has provided influenza vaccines to various federal government customers including the Department of Veterans...
- The U.S. federal government has awarded a $141,185 delivery order contract to Seqirus USA Inc., a global biotechnology company specializing in influenza vaccine development, manufacturing, and delivery. The contract, with a performance period ending on August 30, 2024, is for the supply of influenza virus vaccines. Seqirus USA Inc. is the prime contractor and will be delivering the vaccines under this firm-fixed-price contract. This award is not associated with a set-aside program. Seqirus USA...
- This is a $94,800.00 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Medical Supply Chain to Seqirus USA Inc. for the supply of influenza virus vaccines. The contract has no set-aside designation. Seqirus USA Inc. is a global biotechnology company that specializes in the development, manufacturing, and delivery of influenza vaccines to various federal government agencies, including the Department of Defense, Department of Veterans Affairs, Department of Health and...
- This is a delivery order contract awarded by the Defense Logistics Agency's Medical Supply Chain to Seqirus USA Inc., a foreign-owned, for-profit biotechnology company that specializes in the development, manufacturing, and delivery of influenza vaccines. The contract has a ceiling value of $2,908,197.50 and an ultimate completion date of October 13, 2023. It is a firm fixed-price contract for the delivery of influenza virus vaccines. The contract is not set aside for any specific type of...
- This is a $10,091,030 Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency Troop Support Medical to Seqirus USA Inc. for the delivery of influenza virus vaccines. The contract has a period of performance through September 27, 2024. Seqirus is a global biotechnology company that specializes in the development and delivery of influenza vaccines. The company has been awarded numerous federal contracts and delivery orders to provide influenza vaccines to various...
- This is a firm fixed price delivery order awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 7 to Seqirus USA Inc., a global biotechnology company that specializes in influenza vaccines. The $273,710.00 order is for the delivery of influenza vaccines to support immunization programs run by government agencies. Seqirus has previously received influenza vaccine contracts from federal agencies including the Department of Defense,...
- This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency's Medical Supply Chain to Seqirus USA Inc., a foreign-owned, for-profit biotechnology company, for the provision of influenza virus vaccines. The contract, valued at $12,072,680.00, has an ultimate completion date of October 13, 2023. Seqirus USA Inc. is a global leader in the development, manufacturing, and delivery of influenza vaccines to various federal government agencies. The company holds several...
- This federal contract award, valued at $1,754,655.00, was issued by the Defense Logistics Agency Troop Support Medical to Seqirus USA Inc., a global biotechnology company that specializes in influenza vaccine development and production. The contract is a Delivery Order under a broader Indefinite Delivery Indefinite Quantity (IDIQ) contract, with a firm fixed price pricing type and an ultimate completion date of September 27, 2024. Seqirus USA Inc. has been awarded numerous federal contracts to...
- This is a $4,588,128.50 firm-fixed-price delivery order contract awarded to Seqirus USA Inc., a foreign-owned, for-profit manufacturer of influenza vaccines, by the Defense Logistics Agency's Medical Supply Chain. The contract is for the delivery of influenza virus vaccines and does not have a set-aside designation. Seqirus USA Inc. is a significant federal contractor, holding several large Indefinite Delivery Contracts (IDCs) with agencies like the Department of Veterans Affairs and Centers for...
- This is a firm fixed price delivery order awarded by the Department of Veterans Affairs Veterans Health Administration to Seqirus USA Inc., a global biotechnology company that specializes in influenza vaccines. The $279,979.20 award is for the supply of influenza vaccines to the VA for fiscal year 2018. Seqirus USA Inc. is the prime contractor and has previously held contracts with various federal agencies, including the Department of Defense, Department of Justice Bureau of Prisons, and...
- SPE2DP24D0004Indefinite Delivery Contract
- SPE2DP24D0004-SPE2DP24F3312Delivery Order
This is a delivery order awarded by the Defense Logistics Agency's Medical Supply Chain unit to Seqirus USA Inc., a global biotechnology company that specializes in influenza vaccine development and delivery. The order, valued at $9,597,690.00, is for the supply of influenza virus vaccines. Seqirus USA Inc. has been awarded multiple federal contracts and task orders to provide influenza vaccines to various government healthcare programs and agencies, including the Department of Veterans Affairs, Department of Justice Bureau of Prisons, Department of Health and Human Services (Indian Health Service, Centers for Disease Control and Prevention, and National Institutes of Health), and the Department of Defense. The company holds several high-value Indefinite Delivery Contracts (IDCs) and Indefinite Delivery Indefinite Quantity (IDIQ) contracts to supply these agencies with annual influenza vaccine needs. This delivery order does not have a set-aside designation, likely due to the specialized and proprietary nature of influenza vaccine production.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.6m | 3/19/24 |